Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Operating Expenses (2024 - 2026)

Beta Bionics' Operating Expenses history spans 3 years, with the latest figure at $40.7 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 47.42% to $40.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $140.3 million, a 52.35% increase, with the full-year FY2025 number at $127.2 million, up 56.79% from a year prior.
  • Operating Expenses hit $40.7 million in Q1 2026 for Beta Bionics, up from $35.1 million in the prior quarter.
  • Over the last five years, Operating Expenses for BBNX hit a ceiling of $40.7 million in Q1 2026 and a floor of $16.7 million in Q1 2024.
  • Historically, Operating Expenses has averaged $27.7 million across 3 years, with a median of $27.6 million in 2025.
  • The widest YoY moves for Operating Expenses: up 65.8% in 2025, down 41.83% in 2025.
  • Tracing BBNX's Operating Expenses over 3 years: stood at $24.7 million in 2024, then surged by 41.83% to $35.1 million in 2025, then increased by 16.08% to $40.7 million in 2026.
  • Business Quant data shows Operating Expenses for BBNX at $40.7 million in Q1 2026, $35.1 million in Q4 2025, and $32.2 million in Q3 2025.